Results 201 to 210 of about 213,774 (293)

Migrasomes, Matrix‐Bound Nanovesicles, and More: Messengers in the Matrix

PROTEOMICS, EarlyView.
ABSTRACT Extracellular vesicles (EVs) and particles (EPs) are diverse micro‐ and nanoparticles that circulate in bodily fluids and can attach to, or be deposited onto, the extracellular matrix (ECM) and other surfaces. To date, the nomenclature and classification of matrix‐bound or matrix‐associated EVs and EPs (MEVPs) have been unclear, largely due to
Anna V. Kolesov, Natalie Reitz, Marley Dewey, Colin L. Hisey   +3 more
wiley   +1 more source

Molecular characterization and prognostic modeling of liquid-liquid phase separation-related genes in osteosarcoma based on single-cell sequencing and weighted gene co-expression network analysis. [PDF]

Transl Cancer Res
Huang X, Xiong L, Zeng J, Li S, Cai Y, Zou Z, Yang M, Li H, Liu Y, He M.   +9 more
europepmc   +1 more source

Toward personalizing prosthesis prescription: A take‐home study of three microprocessor‐controlled prosthetic knees: A randomized crossover study

PM&R, EarlyView.
Abstract Background Previous studies on microprocessor‐controlled prosthetic knees (MPKs) often investigate benefits of MPKs as a class of knees rather than clinically relevant differences between specific knees, despite their distinct features. Objectives To systematically evaluate and report outcomes associated with three commercially available MPKs ...
Kinsey Herrin, Sujay Kestur, Sixu Zhou, Gwyn O'Sullivan, Teresa Snow, Walter Lee Childers, Aaron Young   +6 more
wiley   +1 more source

A case of telangiectatic osteosarcoma arising from the frontal bone. [PDF]

Radiol Case Rep
Hayakawa A, Wakabayashi Y, Ishida M, Arizono E, Tanigawa M, Nagao T, Nishida J, Saito K.   +7 more
europepmc   +1 more source

Atomic‐Precision Symmetry Breaking in Bi‐O‐Ti Sites Enables ROS Generation for Bactericidal and Osteosarcoma Therapy

Rare Metals, EarlyView.
ABSTRACT Photocatalytic therapy, which generates reactive oxygen species (ROS) upon light irradiation, has garnered significant interest for antibacterial and anticancer applications. This study establishes a doping‐engineered photocatalytic platform for antibacterial activity and precision osteosarcoma therapy by atomically constructing asymmetric Bi ...
Jun Gu, Haitao Yuan, Bo Chu, Tianqi Wang, Jin Fan, Xuan Sun, Feng Shi, Qinqin Liu, Xiaojun Feng   +8 more
wiley   +1 more source

Time to treatment initiation and overall survival in osteosarcoma: a national cancer database analysis. [PDF]

Bone Jt Open
Farmer SH, O'Brien AC, Feustel PJ, DiCaprio MR.   +3 more
europepmc   +1 more source

New Advances of Degradable Magnesium‐Based Metal Biomaterials in the Field of Orthopedics

Rare Metals, EarlyView.
ABSTRACT Based on their outstanding biomechanical properties and superior osteogenic activity, magnesium (Mg) and its alloys have been extensively investigated for their biocompatibility and therapeutic efficacy in treating fractures and bone defects.
Jia‐Nan Yu, Shao‐Sheng Jia, Rong‐Bang Sun, Tong Zhang, Ling‐Chuang Bai, Di Mei, Shi‐Jie Zhu, Lan Chen, Shao‐Kang Guan   +8 more
wiley   +1 more source

Retraction: MicroRNA-148a Acts as a Tumor Suppressor in Osteosarcoma via Targeting Rho-Associated Coiled-Coil Kinase. [PDF]

Oncol Res
Oncology Research Editorial Office.
europepmc   +1 more source

NQO1‐Responsive Prodrug for in Cellulo Release of Cytochalasin B as Cancer Cell‐Targeted Migrastatic

Small, EarlyView.
The design, synthesis, biochemical, and cell biological evaluation of the NQO1‐targeted prodrug BQTML‐CB is reported. BQTML‐CB selectively releases cytochalasin B upon activation by the quinone‐oxidoreductase NQO1 associated with invasiveness of cancer cells, representing a novel approach to improve cancer selectivity and reduce immunosuppressive ...
Mervic D. Kagho, Katharina Schmidt, Christopher Lambert, Lili Jia, Vignesh Venkatakrishnan, Luisa Mehr, Johan Bylund, Klemens Rottner, Marc Stadler, Theresia E. B. Stradal, Philipp Klahn   +10 more
wiley   +1 more source

Etoposide activates CD8⁺ T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling. [PDF]

J Immunother Cancer
He X, Li H, Wang H, Zuo D, Dong H, Mu H, Yang B, Tao Y, Yang X, Zhao B, Zhang T, Jiang Y, Wang Z, Wang H, Yang L, Hua Y, Cai Z, Wang C, Sun M, Gui J, Sun W.   +20 more
europepmc   +1 more source